–
Lyell Immunopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−215
FY22:
−187
FY23:
−247
FY24:
−359
FY25:
−269
(positive)
Change from FY21 to FY23
millions USD
FY21:
−165
FY22:
−164
FY23:
−214
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY23
millions USD
FY21:
−250
FY22:
−183
FY23:
−235
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−250
FY22:
−183
FY23:
−235
FY24:
−343
FY25:
−274
All amounts in millions USD